Aviral Singh Selected Research

Peptides (Polypeptides)

1/2022	Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results.
1/2019	From Bench to Bedside-The Bad Berka Experience With First-in-Human Studies.
1/2017	Theranostic Perspectives in Prostate Cancer with the Gastrin-Releasing Peptide Receptor Antagonist NeoBOMB1: Preclinical and First Clinical Results.
1/2016	Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for 177Lu-Labeled PSMA-Targeting Peptides.
7/2015	Peptide receptor radionuclide therapy with (90)Y/ (177)Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Aviral Singh Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 01/2016
16	Prostatic Neoplasms (Prostate Cancer) 01/2024 - 01/2016
6	Neoplasm Metastasis (Metastasis) 04/2020 - 01/2018
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2020 - 10/2017
2	Adenocarcinoma 01/2022 - 01/2018
1	Bone Diseases (Bone Disease) 01/2020
1	Nasopharyngeal Carcinoma 12/2019
1	Solitary Kidney 11/2019
1	Lymphedema (Milroy Disease) 06/2019
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2018
1	Leukemia 03/2018
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2017
1	Insulinoma 01/2016
1	Paraganglioma (Paragangliomas) 07/2015

Drug/Important Bio-Agent (IBA)

19	Radioisotopes (Radionuclides)IBA 01/2022 - 07/2015
16	Peptide Receptors (Peptide Receptor)IBA 11/2020 - 07/2015
12	AntigensIBA 01/2024 - 01/2016
9	Somatostatin Receptors (Somatostatin Receptor)IBA 03/2020 - 01/2016
6	LigandsIBA 07/2019 - 01/2016
5	Peptides (Polypeptides)IBA 01/2022 - 07/2015
4	Edotreotide (SMT 487)IBA 04/2020 - 05/2017
4	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 03/2019 - 01/2016
3	PSMA-617IBA 11/2019 - 07/2019
2	Lutetium-177IBA 06/2021 - 01/2019
2	PSMA I&TIBA 07/2019 - 01/2016
2	Bombesin Receptors (Bombesin Receptor)IBA 07/2017 - 01/2017
1	Actinium-225IBA 01/2024
1	68Ga-FAPIIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Docetaxel (Taxotere)FDA Link 06/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 03/2020
1	177Lu-PSMA-617IBA 11/2019
1	gallium 68 PSMA-11IBA 07/2019
1	Hemoglobins (Hemoglobin)IBA 07/2019
1	Alkaline PhosphataseIBA 07/2019
1	taxaneIBA 07/2019
1	Gallium-68IBA 01/2019
1	Yttrium-90IBA 01/2019
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2018
1	GadoliniumIBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Neurotensin Receptors (Neurotensin Receptor)IBA 01/2018
1	BombesinIBA 07/2017
1	Chelating AgentsIBA 07/2017
1	68Ga-SB3IBA 01/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 10/2016
1	Chemokine ReceptorsIBA 01/2016
1	Sunitinib (Sutent)FDA Link 01/2016
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2016
1	Everolimus FDA Link 01/2016

Therapy/Procedure

28	Therapeutics 01/2024 - 07/2015
9	Castration 01/2024 - 01/2016
8	Precision Medicine 01/2019 - 01/2016
3	Radiotherapy 11/2018 - 10/2016
2	Drug Therapy (Chemotherapy) 07/2019 - 01/2016
1	Renal Dialysis (Hemodialysis) 03/2018
1	Aftercare (After-Treatment) 03/2018
1	Cyclotrons 05/2017
1	Gamma Cameras (Gamma Camera) 01/2016